Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.63 |
| ▸ | MEN1 | O00255 | 3/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.63 |
| ▸ | LMNA | P02545 | 4/20 | 0.55 |
| ▸ | HTT | P42858 | 3/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.55 |
| ▸ | MITF | O75030 | 2/20 | 0.55 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | THRB | P10828 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17479278 | 0.82 | MEN1 (0.54) | ALDH1A1MEN1KMT2ALMNAHTT | |
| SCHEMBL31684032 | 0.80 | ALDH1A1 (0.97) | ALDH1A1MEN1KMT2ALMNAHTT | |
| SCHEMBL4555970 | 0.80 | ALDH1A1 (0.97) | ALDH1A1MEN1KMT2ALMNAHTT | |
| SCHEMBL11936027 | 0.80 | ALDH1A1 (0.55) | ALDH1A1MEN1KMT2ALMNAHTT | |
| SCHEMBL15010078 | 0.79 | ALDH1A1 (1.00) | ALDH1A1MEN1KMT2ALMNAHTT | |
| SCHEMBL15952845 | 0.77 | LMNA (0.71) | ALDH1A1KMT2ALMNAHTTNPSR1 | |
| SCHEMBL11229762 | 0.77 | MAPT (0.47) | MEN1KMT2AHTTMAPTNPSR1 | |
| SCHEMBL1001472 | 0.76 | ALDH1A1 (0.62) | ALDH1A1MEN1KMT2ALMNAHTT | |
| SCHEMBL19308071 | 0.76 | KMT2A (0.45) | ALDH1A1MEN1KMT2ALMNANPSR1 | |
| SCHEMBL1000605 | 0.75 | ALDH1A1 (0.78) | ALDH1A1MEN1KMT2ALMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9676747-B2 | Hepatitis B antiviral agents | NOVIRA THERAPEUTICS, INC. (US) | 2017-06-13 | — | — | US | disclosed |